Gilles Rubinstenn

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 259(Granted Patents)

Company Filing History:

Years Active: 2001-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11464751 - Use of fluoroethylnormemantine for the prevention and treatment of anxiety (2022-10-11),

2. 8734692 - Method for compacting a powdery composition at constant volume (2014-05-27),

3. 8420150 - Compact plant powder product, method of making same, and use in preparing a hot drink (2013-04-16),

4. 8361342 - Two-layer compacted solid product for water potabilization and preparation method (2013-01-29),

5. 8100830 - Non-therapeutic methods of evaluating skin neurosensitivity, kit and use of a kit for implementing the method (2012-01-24),

6. 7634103 - Analysis using a three-dimensional facial image (2009-12-15),

7. 7324668 - Feature extraction in beauty analysis (2008-01-29),

8. 7008929 - Sapogenin-based treatment (2006-03-07),

9. 6761697 - Methods and systems for predicting and/or tracking changes in external body conditions (2004-07-13),

10. 6528043 - Composition containing sapogenin (2003-03-04),

11. 6384025 - Retinyl carbonate derivatives, preparation process and uses (2002-05-07),

12. 6331535 - Retinyl carbonate derivatives, preparation process and uses (2001-12-18),

13. 6294157 - Composition containing sapogenin (2001-09-25),

Title: The Innovative Contributions of Gilles Rubinstenn

Introduction

Gilles Rubinstenn is a notable inventor based in Paris, France. He has made significant contributions to the field of innovation, holding a total of 13 patents. His work primarily focuses on advancements in medical treatments and methods for processing materials.

Latest Patents

Among his latest patents is the invention titled "Use of fluoroethylnormemantine for the prevention and treatment of anxiety." This invention relates to the use of fluoroethylnormemantine or its salts for treating anxiety, particularly in post-traumatic stress conditions. It can be used alone or in combination with chemical antidepressants or cognitive and behavioral techniques. Another significant patent is the "Method for compacting a powdery composition at constant volume." This method involves compacting powdery compositions to a reduced volume and maintaining that volume until a solid compact product is achieved.

Career Highlights

Gilles Rubinstenn has worked with prominent companies such as L'Oréal and L'Oréal SA. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the beauty and health industries.

Collaborations

Throughout his career, Rubinstenn has collaborated with notable individuals, including Francis Pruche and Paul Branlard. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Gilles Rubinstenn's contributions to innovation, particularly in the fields of anxiety treatment and material processing, highlight his role as a significant inventor. His patents reflect a commitment to improving lives through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.